A. John Herrmann's most recent trade in Novavax, Inc. was a trade of 2,100 Common Stock done . Disclosure was reported to the exchange on Dec. 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 2,100 | 13,933 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | Herrmann A. John | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 2,100 | 0 | - | - | Restricted Stock Units | |
| Novavax, Inc. | A. John Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.69 per share. | 14 Dec 2023 | 700 | 13,233 (0%) | 0% | 5.7 | 3,983 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2023 | 833 | 0 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2023 | 833 | 12,111 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.70 per share. | 25 Jun 2023 | 278 | 11,833 (0%) | 0% | 6.7 | 1,863 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 4,609 | 9,216 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.52 per share. | 10 Mar 2023 | 4,609 | 13,058 (0%) | 0% | 6.5 | 30,051 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.52 per share. | 10 Mar 2023 | 1,780 | 11,278 (0%) | 0% | 6.5 | 11,606 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 44,280 | 44,280 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 38,330 | 38,330 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,973 | 8,373 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,973 | 0 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 26 Sep 2022 | 1,324 | 7,049 (0%) | 0% | 18.9 | 24,984 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 667 | 0 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 667 | 3,642 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 26 Sep 2022 | 258 | 3,384 (0%) | 0% | 18.9 | 4,868 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 2,000 | 0 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 2,000 | 3,747 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.07 per share. | 24 Aug 2022 | 772 | 2,975 (0%) | 0% | 37.1 | 28,618 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 833 | 833 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 833 | 4,678 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.67 per share. | 25 Jun 2022 | 278 | 4,400 (0%) | 0% | 51.7 | 14,364 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 20,737 | 20,737 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 13,825 | 13,825 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 03 Jan 2022 | 5,000 | 8,845 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 5,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 143.64 per share. | 03 Jan 2022 | 1,003 | 3,945 (0%) | 0% | 143.6 | 144,070 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 139.08 per share. | 03 Jan 2022 | 997 | 7,048 (0%) | 0% | 139.1 | 138,660 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 142.65 per share. | 03 Jan 2022 | 800 | 4,948 (0%) | 0% | 142.6 | 114,117 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 141.69 per share. | 03 Jan 2022 | 800 | 5,748 (0%) | 0% | 141.7 | 113,350 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 140.05 per share. | 03 Jan 2022 | 500 | 6,548 (0%) | 0% | 140.1 | 70,026 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 136.82 per share. | 03 Jan 2022 | 400 | 8,445 (0%) | 0% | 136.8 | 54,728 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 137.85 per share. | 03 Jan 2022 | 400 | 8,045 (0%) | 0% | 137.9 | 55,140 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.43 per share. | 03 Jan 2022 | 100 | 3,845 (0%) | 0% | 144.4 | 14,443 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 5,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 20 Dec 2021 | 5,000 | 8,845 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 20 Dec 2021 | 5,000 | 3,845 (0%) | 0% | 230 | 1,150,000 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,100 | 4,200 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,100 | 4,860 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.43 per share. | 14 Dec 2021 | 1,015 | 3,845 (0%) | 0% | 168.4 | 170,956 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 228.72 per share. | 29 Nov 2021 | 5,000 | 2,760 (0%) | 0% | 228.7 | 1,143,600 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2021 | 5,000 | 95,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 29 Nov 2021 | 5,000 | 7,760 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2021 | 5,000 | 2,760 (0%) | 0% | 200 | 1,000,000 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 03 Nov 2021 | 5,000 | 7,760 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2021 | 5,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 01 Nov 2021 | 5,000 | 7,760 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 5,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 157.42 per share. | 01 Nov 2021 | 800 | 6,260 (0%) | 0% | 157.4 | 125,936 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 170.88 per share. | 01 Nov 2021 | 500 | 3,217 (0%) | 0% | 170.9 | 85,441 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 155.16 per share. | 01 Nov 2021 | 400 | 7,360 (0%) | 0% | 155.2 | 62,065 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 168.32 per share. | 01 Nov 2021 | 400 | 3,917 (0%) | 0% | 168.3 | 67,328 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 162.10 per share. | 01 Nov 2021 | 400 | 5,117 (0%) | 0% | 162.1 | 64,840 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 158.54 per share. | 01 Nov 2021 | 400 | 5,860 (0%) | 0% | 158.5 | 63,414 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 159.90 per share. | 01 Nov 2021 | 343 | 5,517 (0%) | 0% | 159.9 | 54,847 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 172.44 per share. | 01 Nov 2021 | 300 | 2,917 (0%) | 0% | 172.4 | 51,733 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 164.02 per share. | 01 Nov 2021 | 300 | 4,717 (0%) | 0% | 164.0 | 49,205 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 155.96 per share. | 01 Nov 2021 | 300 | 7,060 (0%) | 0% | 156.0 | 46,788 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 169.04 per share. | 01 Nov 2021 | 200 | 3,717 (0%) | 0% | 169.0 | 33,809 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 167.14 per share. | 01 Nov 2021 | 200 | 4,317 (0%) | 0% | 167.1 | 33,429 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 165.66 per share. | 01 Nov 2021 | 200 | 4,517 (0%) | 0% | 165.7 | 33,133 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 173.15 per share. | 01 Nov 2021 | 157 | 2,760 (0%) | 0% | 173.2 | 27,185 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 162.69 per share. | 01 Nov 2021 | 100 | 5,017 (0%) | 0% | 162.7 | 16,269 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 01 Oct 2021 | 5,000 | 7,760 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 5,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 178.00 per share. | 01 Oct 2021 | 600 | 3,560 (0%) | 0% | 178.0 | 106,798 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 171.60 per share. | 01 Oct 2021 | 600 | 6,160 (0%) | 0% | 171.6 | 102,960 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 177.02 per share. | 01 Oct 2021 | 500 | 4,160 (0%) | 0% | 177.0 | 88,509 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 175.91 per share. | 01 Oct 2021 | 500 | 4,660 (0%) | 0% | 175.9 | 87,953 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 174.74 per share. | 01 Oct 2021 | 400 | 5,160 (0%) | 0% | 174.7 | 69,895 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 173.82 per share. | 01 Oct 2021 | 400 | 5,560 (0%) | 0% | 173.8 | 69,530 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 165.40 per share. | 01 Oct 2021 | 400 | 7,360 (0%) | 0% | 165.4 | 66,158 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 179.27 per share. | 01 Oct 2021 | 352 | 3,208 (0%) | 0% | 179.3 | 63,103 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 189.68 per share. | 01 Oct 2021 | 300 | 2,808 (0%) | 0% | 189.7 | 56,905 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 168.03 per share. | 01 Oct 2021 | 300 | 6,960 (0%) | 0% | 168.0 | 50,410 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 172.46 per share. | 01 Oct 2021 | 200 | 5,960 (0%) | 0% | 172.5 | 34,492 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 169.17 per share. | 01 Oct 2021 | 200 | 6,760 (0%) | 0% | 169.2 | 33,834 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 181.36 per share. | 01 Oct 2021 | 100 | 3,108 (0%) | 0% | 181.4 | 18,136 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 166.19 per share. | 01 Oct 2021 | 100 | 7,260 (0%) | 0% | 166.2 | 16,619 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 190.62 per share. | 01 Oct 2021 | 48 | 2,760 (0%) | 0% | 190.6 | 9,150 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2021 | 3,973 | 4,679 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2021 | 3,973 | 3,973 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.16 per share. | 26 Sep 2021 | 1,919 | 2,760 (0%) | 0% | 248.2 | 476,219 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2021 | 666 | 667 | - | - | Restricted Stock Units | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2021 | 666 | 1,969 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.16 per share. | 26 Sep 2021 | 222 | 1,747 (0%) | 0% | 248.2 | 55,092 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 15 Sep 2021 | 5,000 | 5,706 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 5,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 231.91 per share. | 15 Sep 2021 | 1,112 | 1,268 (0%) | 0% | 231.9 | 257,882 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 226.34 per share. | 15 Sep 2021 | 906 | 4,500 (0%) | 0% | 226.3 | 205,061 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 229.57 per share. | 15 Sep 2021 | 800 | 2,880 (0%) | 0% | 229.6 | 183,655 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 227.34 per share. | 15 Sep 2021 | 520 | 3,980 (0%) | 0% | 227.3 | 118,217 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 230.52 per share. | 15 Sep 2021 | 500 | 2,380 (0%) | 0% | 230.5 | 115,260 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 232.57 per share. | 15 Sep 2021 | 300 | 968 (0%) | 0% | 232.6 | 69,771 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 228.22 per share. | 15 Sep 2021 | 300 | 3,680 (0%) | 0% | 228.2 | 68,466 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 234.90 per share. | 15 Sep 2021 | 262 | 706 (0%) | 0% | 234.9 | 61,543 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 224.94 per share. | 15 Sep 2021 | 200 | 5,406 (0%) | 0% | 224.9 | 44,987 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 223.51 per share. | 15 Sep 2021 | 100 | 5,606 (0%) | 0% | 223.5 | 22,351 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 01 Sep 2021 | 5,000 | 5,706 (0%) | 0% | 19.1 | 95,400 | Common Stock |
| Novavax, Inc. | John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 5,000 | 120,000 | - | - | Stock Option (Right to Buy) |